ESAs, Reticulocyte Dynamic and Hemoglobin Variability

计划入组 31 人 · 首次发布于 2012 年 8 月 16 日

Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs

计划入组 45 人 · 首次发布于 2013 年 7 月 22 日

MELD ESAS Evolution: Assessment of the Symptomatic Burden of Patients With Advanced Chronic Liver Disease

计划入组 44 人 · 首次发布于 2023 年 12 月 26 日

SAS

ERAS-801

ERAS-4001

HOKKAIDO PREFECTURAL ESASHI HOSPITAL

Japan

ESSA Pharma

Canada

ESSA PHARMACEUTICALS CORP.

United States

Luspatercept Demonstrates Significant Reduction in Transfusion Burden in Lower-Risk MDS Patients: COMMANDS Trial

GSK's Jesduvroq Receives FDA Approval for Anemia in Dialysis-Dependent CKD Patients

Akebia Prepares Vafseo Launch for Dialysis Patients, Seeks Expansion to Pre-Dialysis Market